A Window of Opportunity to Control the Bacterial Pathogen Pseudomonas aeruginosa Combining Antibiotics and Phages
暂无分享,去创建一个
[1] Sylvain Moineau,et al. Revenge of the phages: defeating bacterial defences , 2013, Nature Reviews Microbiology.
[2] J. Blázquez,et al. Antibiotics and antibiotic resistance: a bitter fight against evolution. , 2013, International journal of medical microbiology : IJMM.
[3] M. Hochberg,et al. Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1 , 2013, Evolutionary applications.
[4] B. B. Finlay,et al. The role of the immune system in governing host-microbe interactions in the intestine , 2013, Nature Immunology.
[5] S. Abedon,et al. Phage cocktails and the future of phage therapy. , 2013, Future microbiology.
[6] S. Zinner,et al. Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model. , 2013, The Journal of antimicrobial chemotherapy.
[7] R. López-Rojas,et al. Emerging therapies for multidrug resistant Acinetobacter baumannii. , 2013, Trends in microbiology.
[8] Heather K. Allen,et al. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals. , 2013, Trends in microbiology.
[9] M. Hochberg,et al. Evolutionary rescue in populations of Pseudomonas fluorescens across an antibiotic gradient , 2013, Evolutionary applications.
[10] O. Kaltz,et al. The probability of evolutionary rescue: towards a quantitative comparison between theory and evolution experiments , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.
[11] A. Buckling,et al. Effects of Sequential and Simultaneous Applications of Bacteriophages on Populations of Pseudomonas aeruginosa In Vitro and in Wax Moth Larvae , 2012, Applied and Environmental Microbiology.
[12] A. Buckling,et al. Introducing yesterday's phage therapy in today's medicine , 2012 .
[13] M. Hochberg,et al. Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage , 2012, Evolutionary applications.
[14] S. West,et al. Mechanisms of Pathogenesis, Infective Dose and Virulence in Human Parasites , 2012, PLoS pathogens.
[15] A. Buckling,et al. Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms , 2012, Evolutionary applications.
[16] S. Gorman,et al. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy , 2011, The Journal of pharmacy and pharmacology.
[17] M. Fischbach. Combination therapies for combating antimicrobial resistance. , 2011, Current opinion in microbiology.
[18] C. Fernandez-Prada,et al. Bacteriophage-Resistant Mutants in Yersinia pestis: Identification of Phage Receptors and Attenuation for Mice , 2011, PloS one.
[19] R. Cantón,et al. Emergence and spread of antibiotic resistance following exposure to antibiotics. , 2011, FEMS microbiology reviews.
[20] R. Hancock,et al. Pseudomonas aeruginosa: all roads lead to resistance. , 2011, Trends in microbiology.
[21] T. Day,et al. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy , 2011, Proceedings of the National Academy of Sciences.
[22] R. MacLean,et al. The Fitness Cost of Rifampicin Resistance in Pseudomonas aeruginosa Depends on Demand for RNA Polymerase , 2011, Genetics.
[23] G. Dougan,et al. Molecular and physiological analysis of three Pseudomonas aeruginosa phages belonging to the “N4-like viruses” , 2010, Virology.
[24] J. Collins,et al. How antibiotics kill bacteria: from targets to networks , 2010, Nature Reviews Microbiology.
[25] B. Murray,et al. Antibiotic-resistant bugs in the 21st century--a clinical super-challenge. , 2009, The New England journal of medicine.
[26] E. Änggård,et al. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic‐resistant Pseudomonas aeruginosa; a preliminary report of efficacy , 2009, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[27] Roy Kishony,et al. Drug interactions and the evolution of antibiotic resistance , 2009, Nature Reviews Microbiology.
[28] R. MacLean,et al. The cost of multiple drug resistance in Pseudomonas aeruginosa , 2009, Journal of evolutionary biology.
[29] Timothy K Lu,et al. Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy , 2009, Proceedings of the National Academy of Sciences.
[30] I. Connerton,et al. Quantitative Models of In Vitro Bacteriophage–Host Dynamics and Their Application to Phage Therapy , 2009, PLoS pathogens.
[31] Remy Chait,et al. Drug interactions modulate the potential for evolution of resistance , 2008, Proceedings of the National Academy of Sciences.
[32] D. Hartl,et al. Accelerated evolution of resistance in multidrug environments , 2008, Proceedings of the National Academy of Sciences.
[33] J. Wierzbowski,et al. Combination drugs, an emerging option for antibacterial therapy. , 2007, Trends in biotechnology.
[34] G. Drusano,et al. Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin , 2007, Antimicrobial Agents and Chemotherapy.
[35] R. Kishony,et al. Antibiotic interactions that select against resistance , 2007, Nature.
[36] François Taddei,et al. Viruses' Life History: Towards a Mechanistic Basis of a Trade-Off between Survival and Reproduction among Phages , 2006, PLoS biology.
[37] A. Buckling,et al. The effect of a bacteriophage on diversification of the opportunistic bacterial pathogen, Pseudomonas aeruginosa , 2005, Proceedings of the Royal Society B: Biological Sciences.
[38] K. Poole. Aminoglycoside Resistance in Pseudomonas aeruginosa , 2005, Antimicrobial Agents and Chemotherapy.
[39] Frederick M. Ausubel,et al. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation , 2002, Nature.
[40] Peter Sander,et al. Mechanisms of Streptomycin Resistance: Selection of Mutations in the 16S rRNA Gene Conferring Resistance , 2001, Antimicrobial Agents and Chemotherapy.
[41] M. Postelnick,et al. The utility of aminoglycosides in an era of emerging drug resistance. , 1998, International journal of antimicrobial agents.
[42] B. Levin,et al. Phage Therapy Revisited: The Population Biology of a Bacterial Infection and Its Treatment with Bacteriophage and Antibiotics , 1996, The American Naturalist.
[43] Rex Consortium,et al. Heterogeneity of selection and the evolution of resistance. , 2013, Trends in ecology & evolution.
[44] G. Darai,et al. N4-like Viruses∗ , 2011 .